Inventor · disambiguated record
Yingzi Xue
Also filed as: XUE YINGZI
11 granted patents·1 pending application·39 citations·filing 2013–2022
88Inventor score
Files withREGENERON PHARMA12
Top patents by PatentIndex Score
12 records- 0196US9565841B2Humanized IL-4 and IL-4Rα animalsREGENERON PHARMA·Filed 2015·Granted Feb 14, 2017·11 cites·14 claims
- 0294US9743647B2Humanized IL-4 and IL-4Ra animalsREGENERON PHARMA·Filed 2015·Granted Aug 29, 2017·7 cites·8 claims
- 0393US10588298B2Humanized IL-4 and IL-4Rα animalsREGENERON PHARMA·Filed 2017·Granted Mar 17, 2020·4 cites·14 claims
- 0492US9591835B2Genetically modified major histocompatibility complex animalsREGENERON PHARMA·Filed 2013·Granted Mar 14, 2017·11 cites·6 claims
- 0587US10477842B2Humanized IL-4 and IL-4Rα animalsREGENERON PHARMA·Filed 2017·Granted Nov 19, 2019·2 cites·17 claims
- 0685US11109578B2Humanized IL-4 and IL-4Ra animalsREGENERON PHARMA·Filed 2019·Granted Sep 7, 2021·1 cites·14 claims
- 0782US12310340B2Humanized IL-4 and IL-4Rα animalsREGENERON PHARMA·Filed 2022·Granted May 27, 2025·0 cites·12 claims
- 0880US10779520B2Genetically modified major histocompatibility complex animalsREGENERON PHARMA·Filed 2018·Granted Sep 22, 2020·1 cites·14 claims
- 0977US11963521B2Humanized IL-4 and IL-4Rα animalsREGENERON PHARMA·Filed 2021·Granted Apr 23, 2024·0 cites·3 claims
- 1077US10045516B2Genetically modified major histocompatibility complex animalsREGENERON PHARMA·Filed 2017·Granted Aug 14, 2018·1 cites·8 claims
- 1176US10314296B2Genetically modified major histocompatibility complex miceREGENERON PHARMA·Filed 2017·Granted Jun 11, 2019·1 cites·18 claims
- 1270US2020375159A1Genetically modified major histocompatibility complex animalsREGENERON PHARMA·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yingzi Xue files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →